The Miriam Hospital
Providence, Rhode Island, 02906, United States
NCT Number: NCT02165254
The purpose of this study is to develop a tai-chi based exercise program designed for patients who recently had a heart attack and do not wish, or are unable, to attend traditional cardiac rehabilitation.
Looking for future studies?
Notify Me21 year–90 year
All sexes
Interventional
Not applicable
Providence, Rhode Island, 02906, United States
We will estimate the feasibility, acceptability and safety of two different doses of the Tai Chi intervention (primary outcome). 60 patients (30 per dose arm) will be randomly assigned to a standard dose of Tai Chi (the dose used by our group in large studies of heart failure patients) or to a high dose matching the recommended frequency and duration of exercise classes in current CRs. Acceptability assessments will include surveys and focus groups to formally assess the impact of Tai Chi on facilitators and barriers to CRs in this population. We will also obtain estimates of effect sizes of each dose on accelerometry measured physical activity and on the proportion of patients achieving the current American Heart Association (AHA) recommendation for physical activity (secondary outcome). Additional outcomes will be cardiac fitness, quality of life, body weight, and sleep. In addition, we will gather exploratory information on possible mechanisms by which Tai Chi training may affect physical activity. We will collect information on possible mediators such as exercise self-efficacy, perceived social support, and depression. In addition, since Tai Chi training is associated with meditative practices aimed at increasing present-moment awareness, we will gather information on mindfulness levels. Measurements will be conducted at baseline, 3-, 6-, and 9 months after enrollment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 hour tai chi session 3 times a week (weeks 1-12), to twice a week (week 13-16), and every other week (week 17-26) for a total of 24 weeks
1 hour tai chi session 3 times a week (weeks 1-12)
Time frame: up to 9 months since enrollment
Time frame: up to 9 months since enrollment
Time frame: up to 6 months since enrollment
Time frame: up to 9 months since enrollment
Time frame: 3, 6, and 9 months since enrollment
Time frame: baseline, 3, 6, 9 months
To estimate mean between-doses differences in physical activity (and other continuous secondary outcomes listed below), we will estimate multivariate linear mixed models for within-participant change since baseline as a function of dose group (high or low), time point (3, 6, and 9 months from enrollment, treated as a categorical variable to allow for non-linear trajectories), and their interaction. A statistically significant interaction indicates that between-group differences vary across time points.
Time frame: baseline, 3,6, and 9 months
Time frame: baseline, 3, 6, and 9 months
Time frame: baseline and intervention completion
Time frame: baseline, 3,6,9 months
Time frame: baseline, 3,6, and 9 months
Time frame: baseline, 3, 6, 9 months
The Miriam Hospital
Other
Development of A Tai-Chi Program To Overcome Barriers To Cardiac Rehabilitation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06686056
Cardiovascular Diseases, Coronary Disease
Beijing, Beijing Municipality, China
View Trial DetailsNCT06759805
Adherence, Medication, Adherence, Treatment
Bergen, Norway
View Trial DetailsNCT07590635
Adherence, Medication, Arterial Occlusive Diseases
Bergen, Norway
View Trial DetailsNCT07259278
Secondary Prevention of Coronary Heart Disease
Beijing, Beijing Municipality, China
View Trial Details